DIA’s Post

Unleashing AI and ML's Impact on #Pharmacovigilance 🔍 New insights reveal the potential of AI and ML in revolutionizing patient safety through PV. A funded paper highlights data's pivotal role in unlocking AI's full potential. Without effective data utilization, #patientsafety efforts might fall short. AI and ML bring hope by managing vast data volumes and navigating uncertainties. Despite challenges like legal frameworks and data diversity, AI/ML can transform PV from data processing to signal detection. These tools enable faster, higher-quality tasks, from #SignalDetection to innovative data analysis methods. At PQE Group our informed expertise keeps itself constantly updated with the evolving needs of the industry. Our team fully understands the opportunities presented by AI and ML and is preparing for this new challenge. Daniela Rota

“New users have been asking how LLMs and chatbots will reshape medicine. Perhaps the reverse question should be ‘How can the intended medical use shape the training of LLMs and chatbots or the other applications they power?’” One of the most well-written short communications I’ve seen around the training of LLMs on medical data, which is something I’ve been wondering a lot about. Thank you JAMA and Nigam Shah! Also, one of the first articles I’ve seen that objectively considers the value proposition of AI: “…there is a risk of falling into the trap of automating tasks that individuals already know how to do, and failing to ask the question of what a person plus such models could do together that may yield better medical care.” Yes! Link in comments. Happy reading. . . . #MedComms #AI #LLM #ChatGPT #MedicalAffairs #Medicine #ArtificialIntelligence

🚀 Exciting advancements in AI are poised to revolutionize regulatory affairs! 🧬 In 2023, GlobalData named Artificial Intelligence (AI) as the top technology set to disrupt the industry. However, while the potential is immense, recent testing with ChatGPT highlights significant challenges. Errors like 'hallucinating' research papers and inventing conclusions demonstrate the current limitations of large language models (LLMs) in providing accurate regulatory information. But fear not! Here are 4️⃣ ways AI is expected to transform regulatory affairs: 1️⃣ AI in Labelling: Helping professionals identify errors and ensure compliance with regulations on product labels. 2️⃣ AI in Regulatory Publishing: Streamlining the submission process by assisting with hyperlinking and bookmarking. 3️⃣ AI in Regulatory Submissions: Automating repetitive tasks and generating complete regulatory documents from templates or clinical trial data. 4️⃣ AI in Regulatory Information and Guidance: Introducing specialized tools like OrcaGPT, trained to provide up-to-date answers on a range of regulatory topics. Watch out for these AI technologies as they aim to accelerate processes and enhance research capabilities in regulatory affairs. While some tools are still in development, the potential impact is undeniable! Excited to see how AI continues to reshape the future of regulatory affairs? Follow #mahendrarathour for more information. Thank you. 🌟 #artificialIntelligence #regulatoryaffairs #biopharmaceuticals #innovation #aitransformations

AI: Good Use in the Medical field?

Transparency, accountability, and governance should always form the pillars of AI in healthcare. WHO recently came out with guidelines on developing generative AI in healthcare for appropriate development, provision, and use. #mlsalgorithm #aiinhealthcare #digitalpathology #iqvia #q2solutions https://lnkd.in/eyt2egqa

📢In case you missed it, please find a link below to download our AI in Healthcare whitepaper 🚀 The rise of Artificial Intelligence (AI) is one of the most significant technological advancements today! Industries like healthcare are integrating AI into their systems, unlocking a world of benefits. 💡 Don't miss out 😎 #AI #healthcare #technology #whitepaper #frazertremble

🏥 At Opticom, we're at the forefront of revolutionizing healthcare, not only, but definitely with AI. 🤖 The WHO's latest guidance on AI ethics and governance underscores the need for balance in AI's risks and rewards. 🎙️ Our approach, centered around in-depth, multilingual interviews with diverse stakeholders, which are all conducted & monitored in-house, ensures every perspective is accounted for: from healthcare workers and patients to technology experts and politicians. It's about understanding beyond words, capturing the essence of diverse views.  🤝 Join us in shaping a healthcare future where AI is as responsible as it is innovative. Let's make health tech not just smarter, but also more sustainable and inclusive.  💡Read more about the WHO's latest guidance: https://lnkd.in/dZTKGGsN #AIinHealthcare #EthicalAI #WHOguidance #BetterDecisions

The Transformative Role of AI in Clinical Research AI's role in clinical rеsеarch is transformativе, offering nеw avеnuеs for drug discovеry, patient care, and mеdical innovation. By еnhancing patiеnt rеcruitmеnt, еnabling data-drivеn insights, and optimizing clinical trial procеssеs, AI has thе potеntial to rеvolutionizе hеalthcarе and improvе patiеnt outcomеs. Howеvеr, addressing еthical concerns and rеgulatory challеngеs is crucial to harnеssing AI's full potential while еnsuring patient safety and data privacy. As AI continues to еvolvе, it holds thе promisе of rеshaping thе futurе of mеdicinе and driving advancеmеnts that will bеnеfit patiеnts worldwidе. Am eager to learn more about the utilization of AI in CR. 😉